Med-Tech Innovation July 16, 2024
Oliver Johnson

Global healthcare AI company Huma Therapeutics Limited has announced the completion of its Series D funding round to cut down the time taken to build and launch a scalable digital health product that meets regulatory demands, as it also launches its Huma Cloud Platform.

The platform offers no code configuration of regulated disease management tools for any therapeutic area, a library of pre-built modules and device connectivity capabilities, a cloud-agnostic framework for flexible hosting, readily available APIs and integration capabilities, the ability to host and deploy diagnostic and predictive AI algorithms, a marketplace, and more to advance digital-first care and research.

The Series D funding round, alongside investments from leading industry partners since its Series C round, created a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article